UT System seeks proposals for UTRGV administrative headquarters

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

AUSTIN – The University of Texas System today posted a request for proposals (RFP) to seek offers for the most suitable site for the administrative headquarters for The University of Texas Rio Grande Valley.

The administrative headquarters for UTRGV will need to accommodate about 100 employees, including staff, professional level and executive level personnel. Considerations will include a proposed site’s access to amenities and major highways – ideally in or near an established commercial district – and access to UTRGV’s campuses.

The RFP, which is posted at https://www.utsystem.edu/reo/RFPsYes.htm, is the first step in selecting a site for the future UTRGV headquarters. UT System staff, assisted by a master planner for the new university, will review and evaluate all proposals and select a site or sites for further evaluation and negotiation. The UT System Board of Regents will make the final decision on selecting the location.

- Advertisement -

In 2013, the Texas Legislature unanimously passed a bill to create UT Rio Grande Valley, a historic move that will combine the resources and assets of UT Brownsville and UT Pan American and, for the first time, make it possible for residents of the Rio Grande Valley to benefit from the Permanent University Fund.

The institution, which will provide an outstanding education to the students of South Texas, Texas, the United States and the world, will also be home to a school of medicine and will transform Texas and the nation by becoming a leader in student success, teaching, research and healthcare.

“This is yet another step on the incredible journey to establish UTRGV as a beacon of opportunity and excellence,” said UT System Chancellor Francisco G. Cigarroa, M.D. “We have come a long way, but there is much work ahead and we are ready for the task. We look forward to seeing the proposals and selecting what will best serve the students, faculty and staff at UTRGV.”

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.

Multicancer Blood Test Detects 17 Cancer Types in Large Prospective Study

A large prospective study published in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.
- Advertisement -